Safety study of NCP112 eye drops in healthy adults
Part of Eyes & vision clinical trials.
This study tests a new eye drop called NCP112 for safety and how well people tolerate it. Healthy volunteers receive the eye drops and are monitored for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 19 and 50 years old.
- You must weigh at least 110 pounds (50 kg) and have a BMI between 18 and 30.
- You cannot have any current or past eye problems (like dry eye, glaucoma, or infections).
- You must not have used any prescription eye drops or dry eye treatments in the past month.
- You must not have had eye surgery or laser vision correction in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different doses of a new eye drop (HUC1-394) to see which dose works best for people with moderate to severe dry eye disease. You may qualify if your dry eye symptoms have lasted at least 3 months and you have low tear production along with other signs of dry eye.
This study tests a new eye drop medicine to see if it is safe and how the body handles it. It is for healthy adults only, not for treating a condition.
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
This early-stage study tests a new eye ointment called RC017 to see how safe it is and how the body handles it. Healthy volunteers will apply the ointment to their eyes once or multiple times so researchers can check for any side effects.
This phase 1 trial tests the safety of an investigational eye drop called IVMED-85 in healthy adults aged 18-49. Participants will receive the eye drops and be monitored for any side effects over 6 weeks.
This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.
Hear when a new Xerophthalmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.